149 related articles for article (PubMed ID: 10155675)
21. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis.
Bate CM; Green JR; Axon AT; Murray FE; Tildesley G; Emmas CE; Taylor MD
Aliment Pharmacol Ther; 1997 Aug; 11(4):755-63. PubMed ID: 9305486
[TBL] [Abstract][Full Text] [Related]
22. Ranitidine 300 mg twice daily and 150 mg four-times daily are effective in healing erosive oesophagitis.
Silver MT; Murdock RH; Morrill BB; Sue SO
Aliment Pharmacol Ther; 1996 Jun; 10(3):373-80. PubMed ID: 8791966
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia.
Kaplan-Machlis B; Spiegler GE; Zodet MW; Revicki DA
Arch Fam Med; 2000 Jul; 9(7):624-30. PubMed ID: 10910310
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
Maton PN; Orlando R; Joelsson B
Aliment Pharmacol Ther; 1999 Jun; 13(6):819-26. PubMed ID: 10383513
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.
Carlsson R; Galmiche JP; Dent J; Lundell L; Frison L
Aliment Pharmacol Ther; 1997 Jun; 11(3):473-82. PubMed ID: 9218069
[TBL] [Abstract][Full Text] [Related]
26. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
[TBL] [Abstract][Full Text] [Related]
27. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
[TBL] [Abstract][Full Text] [Related]
28. Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment.
Annibale B; Franceschi M; Fusillo M; Beni M; Cesana B; Delle Fave G
Hepatogastroenterology; 1998; 45(21):742-51. PubMed ID: 9684126
[TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Harris RA; Kuppermann M; Richter JE
Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
[TBL] [Abstract][Full Text] [Related]
30. Ranitidine for erosive oesophagitis: a double-blind, placebo-controlled study. Glaxo Erosive Esophagitis Study Group.
Roufail W; Belsito A; Robinson M; Barish C; Rubin A
Aliment Pharmacol Ther; 1992 Oct; 6(5):597-607. PubMed ID: 1420751
[TBL] [Abstract][Full Text] [Related]
31. Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice.
Dakkak M; Jones BP; Scott MG; Tooley PJ; Bennett JR
Br J Clin Pract; 1994; 48(1):10-4. PubMed ID: 8179973
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease.
Revicki DA; Sorensen S; Maton PN; Orlando RC
Dig Dis; 1998; 16(5):284-91. PubMed ID: 9892788
[TBL] [Abstract][Full Text] [Related]
33. Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine.
Bardhan KD; Morris P; Thompson M; Dhande DS; Hinchliffe RF; Jones RB; Daly MJ; Carroll NJ
Gut; 1990 Jul; 31(7):745-9. PubMed ID: 2370010
[TBL] [Abstract][Full Text] [Related]
34. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
Dent J; Yeomans ND; Mackinnon M; Reed W; Narielvala FM; Hetzel DJ; Solcia E; Shearman DJ
Gut; 1994 May; 35(5):590-8. PubMed ID: 8200548
[TBL] [Abstract][Full Text] [Related]
35. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Aliment Pharmacol Ther; 1988 Jun; 2(3):221-7. PubMed ID: 2979246
[TBL] [Abstract][Full Text] [Related]
36. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial.
Havelund T; Laursen LS; Skoubo-Kristensen E; Andersen BN; Pedersen SA; Jensen KB; Fenger C; Hanberg-Sørensen F; Lauritsen K
Br Med J (Clin Res Ed); 1988 Jan; 296(6615):89-92. PubMed ID: 3122967
[TBL] [Abstract][Full Text] [Related]
37. Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis.
Eggleston A; Wigerinck A; Huijghebaert S; Dubois D; Haycox A
Gut; 1998 Jan; 42(1):13-6. PubMed ID: 9505878
[TBL] [Abstract][Full Text] [Related]
38. [Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
Dammann HG; Blum AL; Lux G; Rehner M; Riecken EO; Schiessel R; Wienbeck M; Witzel L; Berger J
Dtsch Med Wochenschr; 1986 Jan; 111(4):123-8. PubMed ID: 3510847
[TBL] [Abstract][Full Text] [Related]
39. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
40. Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
Ofman JJ; Yamashita BD; Siddique RM; Larson LR; Willian MK
Am J Manag Care; 2000 Aug; 6(8):905-16. PubMed ID: 11186502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
